Embark on a transformative journey with Benuvia’s Drug Product Formulation services, where innovation meets reliability. Our integrated approach accelerates the development of finished dosage forms, seamlessly integrating API and/or dose manufacturing programs.
Key Highlights:
Integrated Formulation Development
Our integrated approach ensures that formulation development aligns seamlessly with API manufacturing, accelerating the overall drug development process, including novel formulations for cannabinoid-based drugs.
Feasibility Studies
We conduct in-depth feasibility studies to evaluate the viability of different formulation strategies, optimizing the path to a successful final product.
Controlled and Sustained Release
Our formulation expertise spans controlled and sustained release formulations, providing versatility for diverse pharmaceutical products, including cannabinoid-based formulations.
Proprietary Formulation Development
Innovation is at the forefront, with proprietary formulation development strategies for unique and impactful cannabinoid products.
Delivery
Formats
Choose from sub-lingual solutions, oral solutions with droppers or oral syringes, intranasal sprays, and pressurized metered-dose inhalers (pMDI).
Delivery Formats
Our delivery formats are designed to provide flexibility and precision for various therapeutic needs. Choose from sub-lingual solutions, oral solutions with droppers or oral syringes, intranasal sprays, and pressurized metered-dose inhalers (pMDI). Each format ensures optimal delivery and efficacy of our high-quality formulations.
- Intranasa
- Sub-lingual
-
Oral Solution
with dropper -
Oral Solution
with oral syringe - pMDI
pMDI
Oral Solution with oral syringe
Oral Solution with dropper
Sub-lingual
